Editas Medicine's GAAP loss for 2020 was $115.976 million, down 13.3% from $133.746 million in the previous year. Revenue increased 4.4 times to $90.732 million from $20.531 million a year earlier.
Editas Medicine's GAAP loss for 2020 was $115.976 million, down 13.3% from $133.746 million in the previous year. Revenue increased 4.4 times to $90.732 million from $20.531 million a year earlier. 
ir.editasmedicine.com
English (US) 